drug protocol number

20240113

drug sponsor

Amgen Inc./ IQIVIA

drug study

Blinatumomab

drug trial site

King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase